Vascular Solutions Inc. (NASDAQ:VASC) fell 2.8% during trading on Wednesday . The stock traded as low as $44.93 and last traded at $45.07, with a volume of 193,835 shares traded. The stock had previously closed at $46.36.

Several brokerages have commented on VASC. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday. Sidoti lowered shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 target price on the stock. in a research report on Tuesday, July 12th. Piper Jaffray Cos. boosted their target price on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Zacks Investment Research lowered shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, June 29th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $44.13.

The firm has a market cap of $806.01 million and a price-to-earnings ratio of 101.53. The company has a 50 day moving average of $41.45 and a 200-day moving average of $34.48.

Vascular Solutions (NASDAQ:VASC) last issued its earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.03. The company earned $41.20 million during the quarter, compared to analyst estimates of $41.40 million. Vascular Solutions’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.29 earnings per share. Equities research analysts anticipate that Vascular Solutions Inc. will post $1.23 earnings per share for the current fiscal year.

In other Vascular Solutions news, CEO Howard Root sold 34,418 shares of the stock in a transaction on Tuesday, May 24th. The stock was sold at an average price of $39.05, for a total value of $1,344,022.90. Following the sale, the chief executive officer now directly owns 348,340 shares of the company’s stock, valued at $13,602,677. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director John L. Erb sold 10,000 shares of the stock in a transaction on Thursday, April 28th. The stock was sold at an average price of $35.58, for a total value of $355,800.00. Following the completion of the sale, the director now directly owns 10,306 shares in the company, valued at $366,687.48. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Vascular Solutions stock. California State Teachers Retirement System increased its stake in Vascular Solutions Inc. (NASDAQ:VASC) by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,944 shares of the medical device company’s stock after buying an additional 414 shares during the period. California State Teachers Retirement System owned 0.19% of Vascular Solutions worth $1,099,000 at the end of the most recent reporting period.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.